TORVANTA
Compare · data as of 2026-10-05

HIMS vs PATH: HIMS vs PATH

HIMS (HIMS) and PATH (PATH) on Torvanta's measures: HIMS grades higher on 0 of the 4 factor families and PATH on 4.

HIMSPATH
Value graden/aC+
Growth gradeC-A-
Profitability gradeD+B
Momentum gradeD-C+
Market value$6.9B$6.9B
P/E (trailing)n/a19.6x
Forward P/E (Torvanta estimate)n/a13.1x
Revenue, last 12 months$2.6B$1.7B
Revenue growth (y/y)+28%+15%
Operating margin-6.0%8.9%
Return on invested capitaln/a11.4%
Free-cash-flow yield0.9%5.3%
Total return, 1 year-43.5%+2.0%
Total return, 3 years+370.2%-19.0%

Full HIMS analysis · Full PATH analysis

Frequently asked questions

Which is better, HIMS or PATH?

HIMS (HIMS) and PATH (PATH) on Torvanta's measures: HIMS grades higher on 0 of the 4 factor families and PATH on 4. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.

Which is cheaper, HIMS or PATH?

On trailing earnings HIMS trades at n/a and PATH at 19.6x; their value grades are n/a and C+ against their sectors.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer